
Epicor Kinetic is a cloud-first, AI-powered ERP platform for manufacturing environments that require a connected system for transactional, operational, and reporting workflows. The platform supports finance, supply chain, production, inventory, quality, service, analytics, project management, governance and compliance, and global business management. Functional coverage includes planning and scheduling, materials management, shop floor coordination, product management, CRM, field service, electronic reporting, and enterprise content management. Kinetic provides browser-based access, role-based workflows, integration and extensibility tools, IIoT-related capabilities, and deployment options for cloud, on-premises, or hybrid architectures. It can integrate with listed third-party systems for payroll, tax, labeling, procurement, warehouse processes, data capture, and quality workflows, including ADP Workforce Now, Avalara, BarTender, Sage, SourceDay, and Sovos. Epicor Prism adds AI-supported automation and decision support for selected workflows. Kinetic also supports operations across the Americas, EMEA, and APAC and is available in multiple languages, which can matter for distributed manufacturing organizations with regional or multinational requirements.
Learn more
Amazon sellers profit analytics that are accurate Provide detailed information about Amazon fees (e.g. FBA fee, commissions, PPC spend, return cost, promotion costs and your fixed costs (e.g. Virtual Assistant, Prep Center You can also view your data by time period (today or yesterday) and by product. Our flexible charts allow for quick and easy analysis of your Key Performance indicators. Everything can be customized: KPI's (e.g. sales, units profit, return costs etc. The output can be filtered by timeframe and granularity (e.g. last year by month, or last month by day). You can filter the view by product or marketplace (with multi-selection). You can view summary information and drill down into product details for each period. It's a clickable, smart P&L statement that allows you to focus on each parameter (e.g. amazon fees) for each time period.
Learn more
AIATELLA
Cardiovascular diseases result in more than 20 million fatalities globally each year, many of which could be avoided through timely detection. Unfortunately, the healthcare sector is often stretched thin, hindered by the limitations of human analysis capabilities. This is where AIATELLA makes a significant impact. Our innovative AI-driven image analysis technology revolutionizes cardiovascular diagnostics. By automating the intricate measurements of blood vessels and leveraging historical data, we substantially reduce the time, expenses, and required expertise, thereby enhancing the potential for vital imaging procedures. AIATELLA's approach not only accelerates the diagnostic process but also boosts the precision and reliability of results, providing critical measurements and disease progression insights in mere seconds rather than hours. As a result of this increased efficiency and accuracy in analyses, healthcare providers can dedicate more time to patient care, ultimately paving the way for effective preventative strategies and personalized treatment options for everyone. This shift could redefine how we approach cardiovascular health on a global scale.
Learn more
Artrya
Artrya collaborates with healthcare facilities that treat chest pain patients to introduce innovative cardiovascular care models powered by artificial intelligence. This approach seamlessly incorporates high-prognostic plaque characteristics into the assessment of coronary artery disease. It enables swift evaluations of chest pain patients in both emergency and primary care environments. Our vision is a society free from the burden of heart attacks. Leveraging AI-generated insights from coronary computed tomography angiography (CCTA), we can rapidly and accurately classify chest pain patients based on the type and quantity of arterial plaque identified. This allows for quick identification of individuals with little to no coronary artery disease, ensuring that no underlying plaque issues could lead to significant cardiac events in the future. By recognizing early indicators of potential heart attacks, we can effectively confirm at-risk patients with acute or unusual chest pain who may require additional investigation and treatment. Ultimately, this advancement aims to enhance patient outcomes and foster a healthier community.
Learn more